RNTX vs SYF · $80.6M cap vs rev $11.19B
Rein Therapeutics Inc (RNTX) versus SYF (SYF) — a side-by-side from cached financials, not a winner call.
Rein Therapeutics Inc (RNTX) is a biotechnology company listed on NASDAQ.
SYF (SYF) common stock.
Latest reported RNTX revenue for 2026-06-30 was $0. Net income was -$12.2M. RNTX currently screens at market cap $80.6M.
Latest reported SYF revenue for 2026-06-30 was $11.19B. Net income was $1.69B. Revenue was up 99.6% from 2026-03-31 to 2026-06-30. SYF currently screens at market cap $0.
RNTX currently screens at market cap $80.6M. SYF currently screens at market cap $0.
Not investment advice. Open the RNTX and SYF stock pages for the full models.
Not investment advice.